Global Non-Opioid Patch Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Non-Opioid Patch market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Non-Opioid Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Opioid Patch market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Non-Opioid Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Non-Opioid Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Non-Opioid Patch market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Opioid Patch
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Opioid Patch market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NEXGEL Advanced Hydrogel Solutions, Viatris Inc., Johnson and Johnson, Teva Pharmaceutical Industries Ltd and Sorrento Therapeutics Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Non-Opioid Patch market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Non-Opioid Patch product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-Opioid Patch, with price, sales, revenue and global market share of Non-Opioid Patch from 2018 to 2023.
Chapter 3, the Non-Opioid Patch competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Opioid Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-Opioid Patch market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-Opioid Patch.
Chapter 14 and 15, to describe Non-Opioid Patch sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Non-Opioid Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Opioid Patch market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Non-Opioid Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Non-Opioid Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Non-Opioid Patch market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Opioid Patch
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Opioid Patch market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NEXGEL Advanced Hydrogel Solutions, Viatris Inc., Johnson and Johnson, Teva Pharmaceutical Industries Ltd and Sorrento Therapeutics Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Non-Opioid Patch market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Prescription Medicines
- OTC Medicines
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
- NEXGEL Advanced Hydrogel Solutions
- Viatris Inc.
- Johnson and Johnson
- Teva Pharmaceutical Industries Ltd
- Sorrento Therapeutics Inc.
- Hisamitsu Pharmaceutical Co.,Inc.
- Endo International plc.
- Purdue Pharma L.P.
- Amneal Pharmaceuticals LLC
- Grunenthal
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Non-Opioid Patch product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-Opioid Patch, with price, sales, revenue and global market share of Non-Opioid Patch from 2018 to 2023.
Chapter 3, the Non-Opioid Patch competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Opioid Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-Opioid Patch market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-Opioid Patch.
Chapter 14 and 15, to describe Non-Opioid Patch sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-Opioid Patch
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-Opioid Patch Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Prescription Medicines
1.3.3 OTC Medicines
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-Opioid Patch Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Drug Stores
1.4.4 Online Pharmacies
1.5 Global Non-Opioid Patch Market Size & Forecast
1.5.1 Global Non-Opioid Patch Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-Opioid Patch Sales Quantity (2018-2029)
1.5.3 Global Non-Opioid Patch Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 NEXGEL Advanced Hydrogel Solutions
2.1.1 NEXGEL Advanced Hydrogel Solutions Details
2.1.2 NEXGEL Advanced Hydrogel Solutions Major Business
2.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product and Services
2.1.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
2.2 Viatris Inc.
2.2.1 Viatris Inc. Details
2.2.2 Viatris Inc. Major Business
2.2.3 Viatris Inc. Non-Opioid Patch Product and Services
2.2.4 Viatris Inc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Viatris Inc. Recent Developments/Updates
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Non-Opioid Patch Product and Services
2.3.4 Johnson and Johnson Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson and Johnson Recent Developments/Updates
2.4 Teva Pharmaceutical Industries Ltd
2.4.1 Teva Pharmaceutical Industries Ltd Details
2.4.2 Teva Pharmaceutical Industries Ltd Major Business
2.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product and Services
2.4.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.5 Sorrento Therapeutics Inc.
2.5.1 Sorrento Therapeutics Inc. Details
2.5.2 Sorrento Therapeutics Inc. Major Business
2.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Product and Services
2.5.4 Sorrento Therapeutics Inc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sorrento Therapeutics Inc. Recent Developments/Updates
2.6 Hisamitsu Pharmaceutical Co.,Inc.
2.6.1 Hisamitsu Pharmaceutical Co.,Inc. Details
2.6.2 Hisamitsu Pharmaceutical Co.,Inc. Major Business
2.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product and Services
2.6.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
2.7 Endo International plc.
2.7.1 Endo International plc. Details
2.7.2 Endo International plc. Major Business
2.7.3 Endo International plc. Non-Opioid Patch Product and Services
2.7.4 Endo International plc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Endo International plc. Recent Developments/Updates
2.8 Purdue Pharma L.P.
2.8.1 Purdue Pharma L.P. Details
2.8.2 Purdue Pharma L.P. Major Business
2.8.3 Purdue Pharma L.P. Non-Opioid Patch Product and Services
2.8.4 Purdue Pharma L.P. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Purdue Pharma L.P. Recent Developments/Updates
2.9 Amneal Pharmaceuticals LLC
2.9.1 Amneal Pharmaceuticals LLC Details
2.9.2 Amneal Pharmaceuticals LLC Major Business
2.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Product and Services
2.9.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
2.10 Grunenthal
2.10.1 Grunenthal Details
2.10.2 Grunenthal Major Business
2.10.3 Grunenthal Non-Opioid Patch Product and Services
2.10.4 Grunenthal Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Grunenthal Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NON-OPIOID PATCH BY MANUFACTURER
3.1 Global Non-Opioid Patch Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-Opioid Patch Revenue by Manufacturer (2018-2023)
3.3 Global Non-Opioid Patch Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-Opioid Patch by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-Opioid Patch Manufacturer Market Share in 2022
3.4.2 Top 6 Non-Opioid Patch Manufacturer Market Share in 2022
3.5 Non-Opioid Patch Market: Overall Company Footprint Analysis
3.5.1 Non-Opioid Patch Market: Region Footprint
3.5.2 Non-Opioid Patch Market: Company Product Type Footprint
3.5.3 Non-Opioid Patch Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Non-Opioid Patch Market Size by Region
4.1.1 Global Non-Opioid Patch Sales Quantity by Region (2018-2029)
4.1.2 Global Non-Opioid Patch Consumption Value by Region (2018-2029)
4.1.3 Global Non-Opioid Patch Average Price by Region (2018-2029)
4.2 North America Non-Opioid Patch Consumption Value (2018-2029)
4.3 Europe Non-Opioid Patch Consumption Value (2018-2029)
4.4 Asia-Pacific Non-Opioid Patch Consumption Value (2018-2029)
4.5 South America Non-Opioid Patch Consumption Value (2018-2029)
4.6 Middle East and Africa Non-Opioid Patch Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Non-Opioid Patch Sales Quantity by Type (2018-2029)
5.2 Global Non-Opioid Patch Consumption Value by Type (2018-2029)
5.3 Global Non-Opioid Patch Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Non-Opioid Patch Sales Quantity by Application (2018-2029)
6.2 Global Non-Opioid Patch Consumption Value by Application (2018-2029)
6.3 Global Non-Opioid Patch Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Non-Opioid Patch Sales Quantity by Type (2018-2029)
7.2 North America Non-Opioid Patch Sales Quantity by Application (2018-2029)
7.3 North America Non-Opioid Patch Market Size by Country
7.3.1 North America Non-Opioid Patch Sales Quantity by Country (2018-2029)
7.3.2 North America Non-Opioid Patch Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Non-Opioid Patch Sales Quantity by Type (2018-2029)
8.2 Europe Non-Opioid Patch Sales Quantity by Application (2018-2029)
8.3 Europe Non-Opioid Patch Market Size by Country
8.3.1 Europe Non-Opioid Patch Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-Opioid Patch Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Non-Opioid Patch Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-Opioid Patch Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-Opioid Patch Market Size by Region
9.3.1 Asia-Pacific Non-Opioid Patch Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-Opioid Patch Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Non-Opioid Patch Sales Quantity by Type (2018-2029)
10.2 South America Non-Opioid Patch Sales Quantity by Application (2018-2029)
10.3 South America Non-Opioid Patch Market Size by Country
10.3.1 South America Non-Opioid Patch Sales Quantity by Country (2018-2029)
10.3.2 South America Non-Opioid Patch Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Non-Opioid Patch Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-Opioid Patch Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-Opioid Patch Market Size by Country
11.3.1 Middle East & Africa Non-Opioid Patch Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-Opioid Patch Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Non-Opioid Patch Market Drivers
12.2 Non-Opioid Patch Market Restraints
12.3 Non-Opioid Patch Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Non-Opioid Patch and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-Opioid Patch
13.3 Non-Opioid Patch Production Process
13.4 Non-Opioid Patch Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-Opioid Patch Typical Distributors
14.3 Non-Opioid Patch Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Non-Opioid Patch
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-Opioid Patch Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Prescription Medicines
1.3.3 OTC Medicines
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-Opioid Patch Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Drug Stores
1.4.4 Online Pharmacies
1.5 Global Non-Opioid Patch Market Size & Forecast
1.5.1 Global Non-Opioid Patch Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-Opioid Patch Sales Quantity (2018-2029)
1.5.3 Global Non-Opioid Patch Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 NEXGEL Advanced Hydrogel Solutions
2.1.1 NEXGEL Advanced Hydrogel Solutions Details
2.1.2 NEXGEL Advanced Hydrogel Solutions Major Business
2.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product and Services
2.1.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
2.2 Viatris Inc.
2.2.1 Viatris Inc. Details
2.2.2 Viatris Inc. Major Business
2.2.3 Viatris Inc. Non-Opioid Patch Product and Services
2.2.4 Viatris Inc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Viatris Inc. Recent Developments/Updates
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Non-Opioid Patch Product and Services
2.3.4 Johnson and Johnson Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson and Johnson Recent Developments/Updates
2.4 Teva Pharmaceutical Industries Ltd
2.4.1 Teva Pharmaceutical Industries Ltd Details
2.4.2 Teva Pharmaceutical Industries Ltd Major Business
2.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product and Services
2.4.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.5 Sorrento Therapeutics Inc.
2.5.1 Sorrento Therapeutics Inc. Details
2.5.2 Sorrento Therapeutics Inc. Major Business
2.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Product and Services
2.5.4 Sorrento Therapeutics Inc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sorrento Therapeutics Inc. Recent Developments/Updates
2.6 Hisamitsu Pharmaceutical Co.,Inc.
2.6.1 Hisamitsu Pharmaceutical Co.,Inc. Details
2.6.2 Hisamitsu Pharmaceutical Co.,Inc. Major Business
2.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product and Services
2.6.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
2.7 Endo International plc.
2.7.1 Endo International plc. Details
2.7.2 Endo International plc. Major Business
2.7.3 Endo International plc. Non-Opioid Patch Product and Services
2.7.4 Endo International plc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Endo International plc. Recent Developments/Updates
2.8 Purdue Pharma L.P.
2.8.1 Purdue Pharma L.P. Details
2.8.2 Purdue Pharma L.P. Major Business
2.8.3 Purdue Pharma L.P. Non-Opioid Patch Product and Services
2.8.4 Purdue Pharma L.P. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Purdue Pharma L.P. Recent Developments/Updates
2.9 Amneal Pharmaceuticals LLC
2.9.1 Amneal Pharmaceuticals LLC Details
2.9.2 Amneal Pharmaceuticals LLC Major Business
2.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Product and Services
2.9.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
2.10 Grunenthal
2.10.1 Grunenthal Details
2.10.2 Grunenthal Major Business
2.10.3 Grunenthal Non-Opioid Patch Product and Services
2.10.4 Grunenthal Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Grunenthal Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NON-OPIOID PATCH BY MANUFACTURER
3.1 Global Non-Opioid Patch Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-Opioid Patch Revenue by Manufacturer (2018-2023)
3.3 Global Non-Opioid Patch Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-Opioid Patch by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-Opioid Patch Manufacturer Market Share in 2022
3.4.2 Top 6 Non-Opioid Patch Manufacturer Market Share in 2022
3.5 Non-Opioid Patch Market: Overall Company Footprint Analysis
3.5.1 Non-Opioid Patch Market: Region Footprint
3.5.2 Non-Opioid Patch Market: Company Product Type Footprint
3.5.3 Non-Opioid Patch Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Non-Opioid Patch Market Size by Region
4.1.1 Global Non-Opioid Patch Sales Quantity by Region (2018-2029)
4.1.2 Global Non-Opioid Patch Consumption Value by Region (2018-2029)
4.1.3 Global Non-Opioid Patch Average Price by Region (2018-2029)
4.2 North America Non-Opioid Patch Consumption Value (2018-2029)
4.3 Europe Non-Opioid Patch Consumption Value (2018-2029)
4.4 Asia-Pacific Non-Opioid Patch Consumption Value (2018-2029)
4.5 South America Non-Opioid Patch Consumption Value (2018-2029)
4.6 Middle East and Africa Non-Opioid Patch Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Non-Opioid Patch Sales Quantity by Type (2018-2029)
5.2 Global Non-Opioid Patch Consumption Value by Type (2018-2029)
5.3 Global Non-Opioid Patch Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Non-Opioid Patch Sales Quantity by Application (2018-2029)
6.2 Global Non-Opioid Patch Consumption Value by Application (2018-2029)
6.3 Global Non-Opioid Patch Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Non-Opioid Patch Sales Quantity by Type (2018-2029)
7.2 North America Non-Opioid Patch Sales Quantity by Application (2018-2029)
7.3 North America Non-Opioid Patch Market Size by Country
7.3.1 North America Non-Opioid Patch Sales Quantity by Country (2018-2029)
7.3.2 North America Non-Opioid Patch Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Non-Opioid Patch Sales Quantity by Type (2018-2029)
8.2 Europe Non-Opioid Patch Sales Quantity by Application (2018-2029)
8.3 Europe Non-Opioid Patch Market Size by Country
8.3.1 Europe Non-Opioid Patch Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-Opioid Patch Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Non-Opioid Patch Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-Opioid Patch Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-Opioid Patch Market Size by Region
9.3.1 Asia-Pacific Non-Opioid Patch Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-Opioid Patch Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Non-Opioid Patch Sales Quantity by Type (2018-2029)
10.2 South America Non-Opioid Patch Sales Quantity by Application (2018-2029)
10.3 South America Non-Opioid Patch Market Size by Country
10.3.1 South America Non-Opioid Patch Sales Quantity by Country (2018-2029)
10.3.2 South America Non-Opioid Patch Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Non-Opioid Patch Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-Opioid Patch Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-Opioid Patch Market Size by Country
11.3.1 Middle East & Africa Non-Opioid Patch Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-Opioid Patch Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Non-Opioid Patch Market Drivers
12.2 Non-Opioid Patch Market Restraints
12.3 Non-Opioid Patch Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Non-Opioid Patch and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-Opioid Patch
13.3 Non-Opioid Patch Production Process
13.4 Non-Opioid Patch Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-Opioid Patch Typical Distributors
14.3 Non-Opioid Patch Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-Opioid Patch Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Opioid Patch Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. NEXGEL Advanced Hydrogel Solutions Basic Information, Manufacturing Base and Competitors
Table 4. NEXGEL Advanced Hydrogel Solutions Major Business
Table 5. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product and Services
Table 6. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
Table 8. Viatris Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Viatris Inc. Major Business
Table 10. Viatris Inc. Non-Opioid Patch Product and Services
Table 11. Viatris Inc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Viatris Inc. Recent Developments/Updates
Table 13. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson and Johnson Major Business
Table 15. Johnson and Johnson Non-Opioid Patch Product and Services
Table 16. Johnson and Johnson Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Johnson and Johnson Recent Developments/Updates
Table 18. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Teva Pharmaceutical Industries Ltd Major Business
Table 20. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product and Services
Table 21. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 23. Sorrento Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Sorrento Therapeutics Inc. Major Business
Table 25. Sorrento Therapeutics Inc. Non-Opioid Patch Product and Services
Table 26. Sorrento Therapeutics Inc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sorrento Therapeutics Inc. Recent Developments/Updates
Table 28. Hisamitsu Pharmaceutical Co.,Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Hisamitsu Pharmaceutical Co.,Inc. Major Business
Table 30. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product and Services
Table 31. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
Table 33. Endo International plc. Basic Information, Manufacturing Base and Competitors
Table 34. Endo International plc. Major Business
Table 35. Endo International plc. Non-Opioid Patch Product and Services
Table 36. Endo International plc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Endo International plc. Recent Developments/Updates
Table 38. Purdue Pharma L.P. Basic Information, Manufacturing Base and Competitors
Table 39. Purdue Pharma L.P. Major Business
Table 40. Purdue Pharma L.P. Non-Opioid Patch Product and Services
Table 41. Purdue Pharma L.P. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Purdue Pharma L.P. Recent Developments/Updates
Table 43. Amneal Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 44. Amneal Pharmaceuticals LLC Major Business
Table 45. Amneal Pharmaceuticals LLC Non-Opioid Patch Product and Services
Table 46. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 48. Grunenthal Basic Information, Manufacturing Base and Competitors
Table 49. Grunenthal Major Business
Table 50. Grunenthal Non-Opioid Patch Product and Services
Table 51. Grunenthal Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Grunenthal Recent Developments/Updates
Table 53. Global Non-Opioid Patch Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Non-Opioid Patch Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Non-Opioid Patch Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Non-Opioid Patch, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Non-Opioid Patch Production Site of Key Manufacturer
Table 58. Non-Opioid Patch Market: Company Product Type Footprint
Table 59. Non-Opioid Patch Market: Company Product Application Footprint
Table 60. Non-Opioid Patch New Market Entrants and Barriers to Market Entry
Table 61. Non-Opioid Patch Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Non-Opioid Patch Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Non-Opioid Patch Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Non-Opioid Patch Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Non-Opioid Patch Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Non-Opioid Patch Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Non-Opioid Patch Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Non-Opioid Patch Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Non-Opioid Patch Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Non-Opioid Patch Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Non-Opioid Patch Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Non-Opioid Patch Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Non-Opioid Patch Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Non-Opioid Patch Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Non-Opioid Patch Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Non-Opioid Patch Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Non-Opioid Patch Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Non-Opioid Patch Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Non-Opioid Patch Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Non-Opioid Patch Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Non-Opioid Patch Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Non-Opioid Patch Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Non-Opioid Patch Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Non-Opioid Patch Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Non-Opioid Patch Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Non-Opioid Patch Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Non-Opioid Patch Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Non-Opioid Patch Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Non-Opioid Patch Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Non-Opioid Patch Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Non-Opioid Patch Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Non-Opioid Patch Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Non-Opioid Patch Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Non-Opioid Patch Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Non-Opioid Patch Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Non-Opioid Patch Raw Material
Table 121. Key Manufacturers of Non-Opioid Patch Raw Materials
Table 122. Non-Opioid Patch Typical Distributors
Table 123. Non-Opioid Patch Typical Customers
Table 1. Global Non-Opioid Patch Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Opioid Patch Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. NEXGEL Advanced Hydrogel Solutions Basic Information, Manufacturing Base and Competitors
Table 4. NEXGEL Advanced Hydrogel Solutions Major Business
Table 5. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product and Services
Table 6. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
Table 8. Viatris Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Viatris Inc. Major Business
Table 10. Viatris Inc. Non-Opioid Patch Product and Services
Table 11. Viatris Inc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Viatris Inc. Recent Developments/Updates
Table 13. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson and Johnson Major Business
Table 15. Johnson and Johnson Non-Opioid Patch Product and Services
Table 16. Johnson and Johnson Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Johnson and Johnson Recent Developments/Updates
Table 18. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Teva Pharmaceutical Industries Ltd Major Business
Table 20. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product and Services
Table 21. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 23. Sorrento Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Sorrento Therapeutics Inc. Major Business
Table 25. Sorrento Therapeutics Inc. Non-Opioid Patch Product and Services
Table 26. Sorrento Therapeutics Inc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sorrento Therapeutics Inc. Recent Developments/Updates
Table 28. Hisamitsu Pharmaceutical Co.,Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Hisamitsu Pharmaceutical Co.,Inc. Major Business
Table 30. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product and Services
Table 31. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
Table 33. Endo International plc. Basic Information, Manufacturing Base and Competitors
Table 34. Endo International plc. Major Business
Table 35. Endo International plc. Non-Opioid Patch Product and Services
Table 36. Endo International plc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Endo International plc. Recent Developments/Updates
Table 38. Purdue Pharma L.P. Basic Information, Manufacturing Base and Competitors
Table 39. Purdue Pharma L.P. Major Business
Table 40. Purdue Pharma L.P. Non-Opioid Patch Product and Services
Table 41. Purdue Pharma L.P. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Purdue Pharma L.P. Recent Developments/Updates
Table 43. Amneal Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 44. Amneal Pharmaceuticals LLC Major Business
Table 45. Amneal Pharmaceuticals LLC Non-Opioid Patch Product and Services
Table 46. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 48. Grunenthal Basic Information, Manufacturing Base and Competitors
Table 49. Grunenthal Major Business
Table 50. Grunenthal Non-Opioid Patch Product and Services
Table 51. Grunenthal Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Grunenthal Recent Developments/Updates
Table 53. Global Non-Opioid Patch Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Non-Opioid Patch Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Non-Opioid Patch Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Non-Opioid Patch, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Non-Opioid Patch Production Site of Key Manufacturer
Table 58. Non-Opioid Patch Market: Company Product Type Footprint
Table 59. Non-Opioid Patch Market: Company Product Application Footprint
Table 60. Non-Opioid Patch New Market Entrants and Barriers to Market Entry
Table 61. Non-Opioid Patch Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Non-Opioid Patch Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Non-Opioid Patch Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Non-Opioid Patch Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Non-Opioid Patch Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Non-Opioid Patch Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Non-Opioid Patch Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Non-Opioid Patch Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Non-Opioid Patch Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Non-Opioid Patch Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Non-Opioid Patch Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Non-Opioid Patch Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Non-Opioid Patch Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Non-Opioid Patch Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Non-Opioid Patch Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Non-Opioid Patch Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Non-Opioid Patch Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Non-Opioid Patch Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Non-Opioid Patch Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Non-Opioid Patch Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Non-Opioid Patch Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Non-Opioid Patch Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Non-Opioid Patch Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Non-Opioid Patch Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Non-Opioid Patch Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Non-Opioid Patch Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Non-Opioid Patch Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Non-Opioid Patch Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Non-Opioid Patch Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Non-Opioid Patch Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Non-Opioid Patch Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Non-Opioid Patch Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Non-Opioid Patch Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Non-Opioid Patch Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Non-Opioid Patch Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Non-Opioid Patch Raw Material
Table 121. Key Manufacturers of Non-Opioid Patch Raw Materials
Table 122. Non-Opioid Patch Typical Distributors
Table 123. Non-Opioid Patch Typical Customers
LIST OF FIGURES
Figure 1. Non-Opioid Patch Picture
Figure 2. Global Non-Opioid Patch Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Opioid Patch Consumption Value Market Share by Type in 2022
Figure 4. Prescription Medicines Examples
Figure 5. OTC Medicines Examples
Figure 6. Global Non-Opioid Patch Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Non-Opioid Patch Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacies Examples
Figure 9. Drug Stores Examples
Figure 10. Online Pharmacies Examples
Figure 11. Global Non-Opioid Patch Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Non-Opioid Patch Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Non-Opioid Patch Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Non-Opioid Patch Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Non-Opioid Patch Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Non-Opioid Patch Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Non-Opioid Patch by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Non-Opioid Patch Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Non-Opioid Patch Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Non-Opioid Patch Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Non-Opioid Patch Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Non-Opioid Patch Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Non-Opioid Patch Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Non-Opioid Patch Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Non-Opioid Patch Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Non-Opioid Patch Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Non-Opioid Patch Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Non-Opioid Patch Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Non-Opioid Patch Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Non-Opioid Patch Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Non-Opioid Patch Consumption Value Market Share by Region (2018-2029)
Figure 53. China Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Non-Opioid Patch Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Non-Opioid Patch Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Non-Opioid Patch Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Non-Opioid Patch Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Non-Opioid Patch Market Drivers
Figure 74. Non-Opioid Patch Market Restraints
Figure 75. Non-Opioid Patch Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Non-Opioid Patch in 2022
Figure 78. Manufacturing Process Analysis of Non-Opioid Patch
Figure 79. Non-Opioid Patch Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Non-Opioid Patch Picture
Figure 2. Global Non-Opioid Patch Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Opioid Patch Consumption Value Market Share by Type in 2022
Figure 4. Prescription Medicines Examples
Figure 5. OTC Medicines Examples
Figure 6. Global Non-Opioid Patch Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Non-Opioid Patch Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacies Examples
Figure 9. Drug Stores Examples
Figure 10. Online Pharmacies Examples
Figure 11. Global Non-Opioid Patch Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Non-Opioid Patch Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Non-Opioid Patch Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Non-Opioid Patch Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Non-Opioid Patch Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Non-Opioid Patch Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Non-Opioid Patch by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Non-Opioid Patch Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Non-Opioid Patch Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Non-Opioid Patch Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Non-Opioid Patch Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Non-Opioid Patch Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Non-Opioid Patch Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Non-Opioid Patch Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Non-Opioid Patch Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Non-Opioid Patch Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Non-Opioid Patch Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Non-Opioid Patch Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Non-Opioid Patch Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Non-Opioid Patch Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Non-Opioid Patch Consumption Value Market Share by Region (2018-2029)
Figure 53. China Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Non-Opioid Patch Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Non-Opioid Patch Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Non-Opioid Patch Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Non-Opioid Patch Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Non-Opioid Patch Market Drivers
Figure 74. Non-Opioid Patch Market Restraints
Figure 75. Non-Opioid Patch Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Non-Opioid Patch in 2022
Figure 78. Manufacturing Process Analysis of Non-Opioid Patch
Figure 79. Non-Opioid Patch Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
